Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
18,015,668
-
Share change
-
-1,081,221
-
Total reported value
-
$21,790,722
-
Put/Call ratio
-
260%
-
Price per share
-
$1.21
-
Number of holders
-
75
-
Value change
-
-$1,307,830
-
Number of buys
-
32
-
Number of sells
-
28
Institutional Holders of ACELRX PHARMACEUTICALS INC - COM (ACRX) as of Q2 2020
As of 30 Jun 2020,
ACELRX PHARMACEUTICALS INC - COM (ACRX) was held by
75 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,015,668 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, D. E. Shaw & Co., Inc., NORTHERN TRUST CORP, MORGAN STANLEY, Values First Advisors, Inc., BRIDGEWAY CAPITAL MANAGEMENT INC, and Nuveen Asset Management, LLC.
This page lists
75
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.